We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

224 hedge funds and large institutions have $1.17B invested in PDL BioPharma, Inc. in 2013 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 93 increasing their positions, 59 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

265% more call options, than puts

Call options by funds: $12.4M | Put options by funds: $3.4M

58% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 59

44% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 27

9% more capital invested

Capital invested by funds: $1.08B → $1.17B (+$93.2M)

6% more funds holding

Funds holding: 212 → 224 (+12)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
224
Holders Change
+12
Holders Change %
+5.66%
% of All Funds
6.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
39
Increased
93
Reduced
59
Closed
27
Calls
$12.4M
Puts
$3.4M
Net Calls
+$9.02M
Net Calls Change
-$624K

Top Buyers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
+$14.5M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$7.19M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$6.66M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$5.78M
5
Invesco
Invesco
Georgia
+$5.39M

Top Sellers

Rank Fund Capital Flow
1
HSA
Hussman Strategic Advisors
Maryland
-$9.53M
2
GC
Guggenheim Capital
Illinois
-$8.24M
3
Two Sigma Investments
Two Sigma Investments
New York
-$7.8M
4
Principal Financial Group
Principal Financial Group
Iowa
-$6.62M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$5.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
51
McKinley Capital Management
Alaska
$4.14M +$315K +37,437 +8%
IA
52
Icon Advisers
Colorado
$4.05M -$206K -24,400 -5%
CIM
53
Calvert Investment Management
Maryland
$3.89M +$184K +21,788 +5%
California Public Employees Retirement System
54
California Public Employees Retirement System
California
$3.77M +$385K +45,714 +11%
PPA
55
Parametric Portfolio Associates
Washington
$3.64M -$76.5K -9,083 -2%
JIR
56
James Investment Research
Ohio
$3.55M +$237K +28,100 +7%
Two Sigma Investments
57
Two Sigma Investments
New York
$3.5M -$7.8M -926,000 -69%
WBC
58
Westpac Banking Corp
Australia
$3.4M +$1.2M +142,000 +54%
BIM
59
BlackRock Investment Management
Delaware
$3.27M -$89.4K -10,603 -3%
CBOA
60
Commonwealth Bank of Australia
Australia
$3.25M +$138K +16,400 +4%
Asset Management One
61
Asset Management One
Japan
$3.23M +$363K +43,111 +13%
TCM
62
Tributary Capital Management
Nebraska
$3.23M +$82.4K +9,777 +3%
Axa
63
Axa
France
$2.98M +$682K +80,900 +30%
GF
64
Gerstein Fisher
New York
$2.8M +$272K +32,264 +100%
Robeco Institutional Asset Management
65
Robeco Institutional Asset Management
Netherlands
$2.8M +$2.8M +332,058 New
AQR Capital Management
66
AQR Capital Management
Connecticut
$2.74M -$2.97M -352,861 -52%
BCM
67
Bridgeway Capital Management
Texas
$2.7M +$187K +22,200 +7%
Goldman Sachs
68
Goldman Sachs
New York
$2.54M -$3.85M -456,599 -60%
CIP
69
Convergence Investment Partners
Florida
$2.48M +$2.33M +276,154 +1,620%
AllianceBernstein
70
AllianceBernstein
Tennessee
$2.41M -$148K -17,578 -6%
IG
71
ING Group
Netherlands
$2.39M +$98.7K +11,707 +4%
MPM
72
Meritage Portfolio Management
Kansas
$2.32M -$15.6K -1,850 -0.7%
Principal Financial Group
73
Principal Financial Group
Iowa
$2.25M -$6.62M -785,488 -75%
Nomura Holdings
74
Nomura Holdings
Japan
$2.21M +$444K +52,635 +25%
California State Teachers Retirement System (CalSTRS)
75
California State Teachers Retirement System (CalSTRS)
California
$2.14M +$13.5K +1,600 +0.6%
1 2
3
4 5

PDLI Hedge Fund Activity: Q4 2013 in Review

224 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q4 2013, worth a combined $1.17B — up 8.7% from $1.08B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new PDLI positions and 27 closed out — a net gain of 12 holders — while 93 added to existing stakes and 59 trimmed.

The largest buyer was Numeric Investors, adding an estimated $14.5M. The largest seller was Hussman Strategic Advisors, cutting an estimated $9.53M.

  • 224 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q4 2013, up from 212 in Q3 2013.
  • Funds reported $1.17B of PDL BioPharma, Inc. stock for Q4 2013, up 8.7% quarter-over-quarter.
  • 39 funds opened new PDL BioPharma, Inc. positions in Q4 2013 and 27 closed out, a net change of +12 holders.
  • The largest PDL BioPharma, Inc. buyer in Q4 2013 was Numeric Investors, an estimated $14.5M added.
  • The largest PDL BioPharma, Inc. seller in Q4 2013 was Hussman Strategic Advisors, an estimated $9.53M sold.

Based on aggregated 13F filings for Q4 2013.